Pharmacokinetic Study of Oxidized Dextrans

A. A. Starostenko; A. V. Troitskii; V. S. Medvedev; E. P. Gulyaeva; T. N. Bystrova; V. A. Shkurupii

doi:10.1007/s11094-016-1373-6

Pharmacokinetic Study of Oxidized Dextrans

Авторы: Starostenko A.A.¹, Troitskii A.V.¹, Medvedev V.S.¹, Gulyaeva E.P.¹, Bystrova T.N.¹, Shkurupii V.A.¹
Учреждения:
1. Institute of Experimental and Clinical Medicine, Siberian Branch, Russian Academy of Medical Sciences
Выпуск: Том 49, № 12 (2016)
Страницы: 795-797
Раздел: Molecular-Biological Problems of Drug Design and Mechanism of Drug Action
URL: https://bakhtiniada.ru/0091-150X/article/view/244294
DOI: https://doi.org/10.1007/s11094-016-1373-6
ID: 244294

Цитировать

Полный текст

Открытый доступ
Доступ закрыт

Доступ предоставлен
Доступ закрыт

Только для подписчиков

Аннотация
Об авторах
Список литературы
Дополнительные файлы
Статистика

Аннотация

Methods of obtaining biotinylated oxidized dextran (BTOD) and procedures for pharmacokinetic studies of BTOD and biotinylated dextran (BTD) are described. The pharmacokinetics results showed that there are no differences in principle between the oxidized and unoxidized dextrans. All studied dextrans were characterized by two-phase pharmacokinetic profiles after intraperitoneal and subcutaneous administration.

Ключевые слова

oxidized dextran, pharmacokinetics, biotin, immunoenzymatic assay

Об авторах

A. Starostenko

Institute of Experimental and Clinical Medicine, Siberian Branch, Russian Academy of Medical Sciences